Preventing Severe Chemotherapy-Induced Reactivation of Hepatitis B – Time to Adopt a Universal Approach William Sievert Invited Commentary 29 September 2012 Pages: 195 - 196
Screening and Management of Hepatocellular Carcinoma: The Australian Perspective Anouk DevVirginia Knight Global Perspectives: Australia (W Sievert, Section Editor) 27 October 2012 Pages: 197 - 205
Preventing Perinatal Transmission of HBV: An Australian Perspective Miriam T. Levy Global Perspectives: Australia (W Sievert, Section Editor) 25 August 2012 Pages: 206 - 212
Global Perspectives: Australia – Real World Experience with HBV Antiviral Therapy Dilip RatnamPeter Angus Global Perspectives: Australia (W Sievert, Section Editor) 07 October 2012 Pages: 213 - 220
Acute Hepatitis C Infection: New Approaches to Surveillance, Treatment and Prevention Joseph S. DoyleRachel Sacks-DavisMargaret E. Hellard Global Perspectives: Australia (W Sievert, Section Editor) 23 August 2012 Pages: 221 - 230
Biomarkers of Fibrosis and Fibrosis Progression in Chronic Hepatitis C Jacinta A. HolmesAlexander J. ThompsonLeon A. Adams Global Perspectives: Australia (W Sievert, Section Editor) 02 September 2012 Pages: 231 - 242
Clinical Implications of the Innate and Adaptive Immune Response to HBV and HCV Suong T. LeKumar Visvanathan Global Perspectives: Australia (W Sievert, Section Editor) 22 August 2012 Pages: 243 - 249
Treatment of Chronic HCV Genotype 4 Infection G. EsmatM. El RazikyM. E. Gamil Global Perspectives: Middle East (SM Alavian and AI Sharara, Section Editors) 24 August 2012 Pages: 250 - 255
Treatment of Chronic HCV in Special Populations: Thalassemia, Hemophilia, and Hemodialysis Patients Seyed Moayed AlavianKamran Bagheri LankaraniAla I. Sharara Global Perspectives: Middle East (SM Alavian and AI Sharara, Section Editors) 31 August 2012 Pages: 256 - 262
Interferon-based Therapy for e-antigen Negative Chronic Hepatitis B Virus Infection Fayaz A. HandooHamdan AlGhamdiIbrahim H. Altraif Global Perspectives: Middle East (SM Alavian and AI Sharara, Section Editors) 26 August 2012 Pages: 263 - 271
Hepatitis D in the Middle East and North Africa (MENA): Update and Challenges Ahead Nada MelhemSoha YazbekSami Ramia Global Perspectives: Middle East (SM Alavian and AI Sharara, Section Editors) 25 August 2012 Pages: 272 - 278
The Role of Interferon Therapy in Patients with Hepatocellular Carcinoma Mark W. Russo ReviewPaper 16 December 2010 Pages: 279 - 285
Cholestatic Hepatitis C in Immunocompromised Settings Isabel A. ZachariasFredric D. Gordon ReviewPaper 03 December 2010 Pages: 286 - 291